Pharmaceuticals News and Research

RSS

Researchers win Kaye prize for gastro-retentive sustained release drug delivery system

Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.

9 Jun 2004

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

A chemotherapy regimen commonly used to treat non-small cell lung cancer is both more effective and more toxic in Japanese patients than in American patients, researchers reported Saturday at the annual meeting of the American Society of Clinical Oncologists.

7 Jun 2004

Australian scientists have developed a tool that acts as a pregnancy test for the detection of anthrax

Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.

7 Jun 2004

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

CSIRO is mounting a major display of technologies this week at BIO 2004, the world's largest biotechnology conference, being held in San Francisco, USA, from 6-9 June.

7 Jun 2004

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

A new multi-targeted anticancer drug called SU11248 has shown very promising results in the treatment for metastatic renal cell cancer, one of the most chemotherapy resistant of all cancers.

6 Jun 2004

Velcade major improvement over standard therapy for relapsed multiple myeloma

Early results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease, researchers at Dana-Farber Cancer Institute report.

6 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Five major prescription drug manufacturers make drugs available to Medicare discount cardholders

The Pharmacy Care Alliance (PCA) today announced that AstraZeneca, Johnson & Johnson Pharmaceutical Companies, Inc., Eli Lilly and Company, Merck and Novartis will make many prescription drugs available to qualifying PCA Medicare discount cardholders free of charges from the manufacturer plus a nominal amount to cover dispensing, processing and other costs.

5 Jun 2004

New generation drug therapy targets the individual

The days of ‘one size fits all’ medicines may soon be a thing of the past for people undergoing radical drug therapies for chronic or serious illnesses.

5 Jun 2004

GlaxoSmithKline statement on spat with Spitzer

GlaxoSmithKline has acted responsibly in conducting clinical studies in pediatric patients and disseminating data from those studies. All pediatric studies have been made available to the FDA and regulatory agencies worldwide.

3 Jun 2004

Democrats air their views on Medicare prescription drugs discount cards

On Tuesday the new Medicare prescription drugs discount cards went into effect. The enrollment process is so confusing, most seniors are not signing up for the cards. Those that have will quickly discover the cards don’t deliver the savings they were promised.

3 Jun 2004

Drug helps children with attention deficit/hyperactivity disorder (ADHD)

Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.

3 Jun 2004

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.

3 Jun 2004

Reliability of medical research in Britain today questioned by the general public

Doctors, patients and the general public depend on results of scientific research to provide information about the safety and effectiveness of medical treatments. Following the controversy surrounding the Andrew Wakefield study on the link between MMR vaccines and autism, the public is now considering the reliability of medical research in Britain today.

2 Jun 2004

HHS urges people to sign up for Medicare-approved drug discount cards

HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.

2 Jun 2004

Tuberculosis test kits order

Medical Services International Inc.has announced that it has received its first order for the VScan Tuberculosis (TB) rapid test kit from a prominent pharmaceutical company that produces Tuberculosis vaccines.

2 Jun 2004

New medical patent covering the generation of genetically enhanced therapeutic antigens

Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.

2 Jun 2004

Radiological imaging system that will give medics a clearer view inside the human body

EUREKA project E! 2427 PERMON is developing a radiological imaging system that will give medics a clearer view inside the human body by accurately monitoring organ blood flow during operations. This essential information will lead to an increase in techniques such as laser surgery over more invasive methods.

2 Jun 2004

BioSante publishes oral insulin study

BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.

2 Jun 2004

Pharmaceuticals News and Research

Researchers win Kaye prize for gastro-retentive sustained release drug delivery system

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Australian scientists have developed a tool that acts as a pregnancy test for the detection of anthrax

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

Velcade major improvement over standard therapy for relapsed multiple myeloma

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Drug Tarceva improves survival chance for patients with advanced lung cancer

Five major prescription drug manufacturers make drugs available to Medicare discount cardholders

New generation drug therapy targets the individual

GlaxoSmithKline statement on spat with Spitzer

Democrats air their views on Medicare prescription drugs discount cards

Drug helps children with attention deficit/hyperactivity disorder (ADHD)

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Reliability of medical research in Britain today questioned by the general public

HHS urges people to sign up for Medicare-approved drug discount cards

Tuberculosis test kits order

New medical patent covering the generation of genetically enhanced therapeutic antigens

Radiological imaging system that will give medics a clearer view inside the human body

BioSante publishes oral insulin study

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News